BACKGROUND: We examined the epidemiology of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) nasal colonization among 3 groups of human immunodeficiency virus (HIV)-infected and 1 group of HIV-negative outpatients. METHODS: We determined prevalence and risk factors associated with MRSA colonization among women, recently incarcerated, and Hispanic HIV-infected patients and HIV-negative patients; isolates were typed by pulsed-field gel electrophoresis. Relative prevalence was calculated using Poisson regression, and logistic regression was used for multivariate analysis. RESULTS: Of 601 patients, 9.3% were colonized with MRSA; 11% of HIV-infected and 4.2% of HIV-negative patients were colonized (relative prevalence, 2.6; 95% confidence interval [CI], 1.12-6.07; P = .03). Among HIV-infected patients, recently incarcerated patients had the highest colonization prevalence (15.6%) followed by women (12%); Hispanic patients had the lowest (2.8%). Eighty percent of confirmed MRSA isolates were identified as USA300. On multivariate analysis, history of incarceration or residence in alternative housing (odds ratio [OR], 2.3; 95% CI, 1.1-4.7; P = .03) was associated with MRSA colonization; Hispanic ethnicity was negatively associated (OR, 0.3; 95% CI, .11-.98; P = .045). There was a trend (OR, 1.6; 95% CI, .9-3.0; P = .097) toward geographic location of residence being associated with colonization. After controlling for incarceration, residence, and geography, HIV status was no longer significantly associated with colonization. CONCLUSIONS: The CA-MRSA and HIV epidemics have intersected. Examination of networks of individuals released from incarceration, both HIV positive and negative, is needed to assess the role of social networks in spread of CA-MRSA and inform prevention strategies.
BACKGROUND: We examined the epidemiology of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) nasal colonization among 3 groups of human immunodeficiency virus (HIV)-infected and 1 group of HIV-negative outpatients. METHODS: We determined prevalence and risk factors associated with MRSA colonization among women, recently incarcerated, and Hispanic HIV-infectedpatients and HIV-negative patients; isolates were typed by pulsed-field gel electrophoresis. Relative prevalence was calculated using Poisson regression, and logistic regression was used for multivariate analysis. RESULTS: Of 601 patients, 9.3% were colonized with MRSA; 11% of HIV-infected and 4.2% of HIV-negative patients were colonized (relative prevalence, 2.6; 95% confidence interval [CI], 1.12-6.07; P = .03). Among HIV-infectedpatients, recently incarcerated patients had the highest colonization prevalence (15.6%) followed by women (12%); Hispanic patients had the lowest (2.8%). Eighty percent of confirmed MRSA isolates were identified as USA300. On multivariate analysis, history of incarceration or residence in alternative housing (odds ratio [OR], 2.3; 95% CI, 1.1-4.7; P = .03) was associated with MRSA colonization; Hispanic ethnicity was negatively associated (OR, 0.3; 95% CI, .11-.98; P = .045). There was a trend (OR, 1.6; 95% CI, .9-3.0; P = .097) toward geographic location of residence being associated with colonization. After controlling for incarceration, residence, and geography, HIV status was no longer significantly associated with colonization. CONCLUSIONS: The CA-MRSA and HIV epidemics have intersected. Examination of networks of individuals released from incarceration, both HIV positive and negative, is needed to assess the role of social networks in spread of CA-MRSA and inform prevention strategies.
Authors: Fred C Tenover; Linda K McDougal; Richard V Goering; George Killgore; Steven J Projan; Jean B Patel; Paul M Dunman Journal: J Clin Microbiol Date: 2006-01 Impact factor: 5.948
Authors: Wm Christopher Mathews; Joseph C Caperna; R Edward Barber; Francesca J Torriani; Loren G Miller; Susanne May; J Allen McCutchan Journal: J Acquir Immune Defic Syndr Date: 2005-10-01 Impact factor: 3.731
Authors: Sophia V Kazakova; Jeffrey C Hageman; Matthew Matava; Arjun Srinivasan; Larry Phelan; Bernard Garfinkel; Thomas Boo; Sigrid McAllister; Jim Anderson; Bette Jensen; Doug Dodson; David Lonsway; Linda K McDougal; Matthew Arduino; Victoria J Fraser; George Killgore; Fred C Tenover; Sara Cody; Daniel B Jernigan Journal: N Engl J Med Date: 2005-02-03 Impact factor: 91.245
Authors: M H Nguyen; C A Kauffman; R P Goodman; C Squier; R D Arbeit; N Singh; M M Wagener; V L Yu Journal: Ann Intern Med Date: 1999-02-02 Impact factor: 25.391
Authors: David M Hartley; Jon P Furuno; Marc O Wright; David L Smith; Eli N Perencevich Journal: Infect Control Hosp Epidemiol Date: 2006-02-08 Impact factor: 3.254
Authors: Kyle J Popovich; Evan Snitkin; Stefan J Green; Alla Aroutcheva; Mary K Hayden; Bala Hota; Robert A Weinstein Journal: Clin Infect Dis Date: 2015-09-07 Impact factor: 9.079
Authors: Kyle J Popovich; Evan S Snitkin; Bala Hota; Stefan J Green; Ali Pirani; Alla Aroutcheva; Robert A Weinstein Journal: J Infect Dis Date: 2017-06-01 Impact factor: 5.226
Authors: Jason E Farley; Laura E Starbird; Jill Anderson; Nancy A Perrin; Kelly Lowensen; Tracy Ross; Karen C Carroll Journal: Am J Infect Control Date: 2017-07-03 Impact factor: 2.918
Authors: Kyle J Popovich; Bala Hota; Alla Aroutcheva; Lisa Kurien; Janki Patel; Rosie Lyles-Banks; Amanda E Grasso; Andrej Spec; Kathleen G Beavis; Mary K Hayden; Robert A Weinstein Journal: Clin Infect Dis Date: 2013-01-16 Impact factor: 9.079
Authors: Kyle J Popovich; Evan S Snitkin; Chad Zawitz; Alla Aroutcheva; Darjai Payne; Stephanie N Thiede; Michael Schoeny; Stefan J Green; Mary K Hayden; Bala Hota; Robert A Weinstein Journal: Clin Infect Dis Date: 2020-07-11 Impact factor: 9.079
Authors: Kyle J Popovich; Stephanie N Thiede; Chad Zawitz; Alla Aroutcheva; Darjai Payne; William Janda; Michael Schoeny; Stefan J Green; Evan S Snitkin; Robert A Weinstein Journal: Clin Infect Dis Date: 2021-12-06 Impact factor: 9.079
Authors: Win Mar Kyaw; Linda Kay Lee; Wong Chia Siong; Angela Chow Li Ping; Brenda Ang; Yee Sin Leo Journal: AIDS Res Ther Date: 2012-11-06 Impact factor: 2.250